BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs

  BioCardia®, Inc. announced a clarification and next steps on its autologous CardiAMP cell therapy programs.

  September 6, 2023

   · 

  6 min read
• Pharm Country

  LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

  LAVATherapeutics N.V. announced that Stephen Hurly, president and chief executive officer of LAVA Therapeutics, will participate in a virtual fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference which will be available on Monday, September 11, 2023 at 7:00 am ET.

  September 6, 2023

   · 

  1 min read
• Pharm Country

  EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil

  EOM Pharmaceutical Holdings, Inc announced the results of its completed clinical trial in hospitalized COVID-19 patients with severe symptoms treated with its investigational immune-regulating drug product EOM613.

  September 6, 2023

   · 

  8 min read
• Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference

  Oncolytics Biotech® Inc. announced that Chief Executive Officer Dr. Matt Coffey will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023 at the Lotte New York Palace Hotel in New York, NY.

  September 6, 2023

   · 

  1 min read
• Business

  TriSalus Life Sciences Appoints Jodi Devlin as President of TriSalus Therapeutics

  TriSalus Life Sciences® Inc., an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced that Jodi Devlin has joined the Company as President of TriSalus Therapeutics.

  September 6, 2023

   · 

  4 min read
• Business

  Biogen Appoints Jane Grogan as Head of Research

  Biogen Inc. (Nasdaq: BIIB) announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023.

  September 6, 2023

   · 

  6 min read
• Biotech Bay

  Harpoon Therapeutics Abstract for HPN217 Accepted for Poster Presentation at the 20th International Myeloma Society Annual Meeting

  Harpoon Therapeutics, Inc. today announced abstract acceptance and a poster presentation of preliminary data (up to and including 12mg cohorts) from the dose escalation portion of the Phase 1 study of HPN217 in patients with relapsed/refractory multiple myeloma.

  September 6, 2023

   · 

  3 min read
• BioCapital

  60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference

  60 Degrees Pharmaceuticals Inc. announced today that CEO Dr. Geoff Dow and CFO Ty Miller will participate in the H.C. Wainwright 25th Annual Global Investment Conference.

  September 6, 2023

   · 

  1 min read
• Pharm Country

  Teleneurology Challenges Met by Training Curriculum

  A new physician-training system in telehealth simulates key parts of traditional, in-person neurological exams that use little reflex hammers, pinpricks, and flashlights to test nerve function.

  September 6, 2023

   · 

  4 min read
• BioMidwest

  Redwire to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11, 2023

  Redwire Corporation, a leader in space infrastructure for the next generation space economy, announced that Redwire Chairman and Chief Executive Officer Peter Cannito and Chief Financial Officer Jonathan Baliff will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference.

  September 6, 2023

   · 

  1 min read